Main Street Research’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,338
| Closed | -$800K | – | 125 |
|
|
2025
Q1 | $800K | Sell |
11,338
-74,465
| -87% | -$5.26M | 0.05% | 62 |
|
|
2024
Q4 | $7.38M | Sell |
85,803
-376,265
| -81% | -$32.4M | 0.46% | 35 |
|
|
2024
Q3 | $55M | Buy |
462,068
+981
| +0.2% | +$117K | 3.46% | 7 |
|
|
2024
Q2 | $65.8M | Sell |
461,087
-1,225
| -0.3% | -$175K | 4.34% | 3 |
|
|
2024
Q1 | $59.8M | Sell |
462,312
-4,534
| -1% | -$586K | 4.06% | 3 |
|
|
2023
Q4 | $48.3M | Sell |
466,846
-8,516
| -2% | -$881K | 3.88% | 4 |
|
|
2023
Q3 | $43.2M | Sell |
475,362
-8,906
| -2% | -$810K | 4.45% | 4 |
|
|
2023
Q2 | $39.2M | Buy |
484,268
+6,046
| +1% | +$489K | 6.25% | 4 |
|
|
2023
Q1 | $38.3M | Sell |
478,222
-4,388
| -0.9% | -$352K | 7.57% | 3 |
|
|
2022
Q4 | $32.7M | Buy |
482,610
+4,774
| +1% | +$323K | 7.95% | 4 |
|
|
2022
Q3 | $23.8M | Buy |
477,836
+9,600
| +2% | +$478K | 5.24% | 8 |
|
|
2022
Q2 | $26.1M | Buy |
468,236
+2,096
| +0.4% | +$117K | 6.84% | 6 |
|
|
2022
Q1 | $25.9M | Buy |
+466,140
| New | +$25.9M | 2.43% | 18 |
|